Christian Sonesson
Corporate Officer/Principal bij EGETIS THERAPEUTICS AB
Vermogen: 11 044 $ op 30-04-2024
Oorsprong van het eerstegraads netwerk van Christian Sonesson
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 25 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Christian Sonesson via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal | |
| ASTRAZENECA PLC | Pharmaceuticals: Major | Public Communications Contact Investor Relations Contact | |
Janssen Pharmaceuticals, Inc.
 Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Janssen Pharmaceuticals, Inc. develops and markets prescription drugs in various therapeutic areas, including attention deficit hyperactivity disorder, pain management, acid reflux and infectious diseases, women’s health, and mental health (bipolar I disorder and schizophrenia); and neurologic, including Alzheimer’s disease, epilepsy, and migraine prevention and treatment. Its products include Axert, Darzalezx, Invokamet XR, Invokana, Remicade, Reopro, and Risperdal Consta. The company was founded by Paul Janssen in 1953 and is headquartered in Titusville, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| GALAPAGOS NV | Biotechnology | Director/Board Member | |
| SECTRA AB | Packaged Software | Corporate Officer/Principal | |
| MEDIVIR AB | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
| BIOGAIA AB | Pharmaceuticals: Other | Compliance Officer | |
AstraZeneca AB
 AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| Karolinska Institutet | College/University | Doctorate Degree Undergraduate Degree | |
| ANALYTICA | Medical Specialties | Director/Board Member | |
| Chalmers University of Technology | College/University | Graduate Degree | |
| Stockholm School of Economics | College/University | Masters Business Admin Masters Business Admin | |
| University of Uppsala | College/University | Doctorate Degree Doctorate Degree Graduate Degree Graduate Degree Doctorate Degree Doctorate Degree Doctorate Degree Masters Business Admin Undergraduate Degree | |
LEO Pharma A/S
 LEO Pharma A/S Pharmaceuticals: MajorHealth Technology LEO Pharma A/S develops, manufactures and markets drugs within the area of dermatology and critical care medicine. It supplies medicines to patients suffering from skin infections and diseases such as psoriasis and eczema, thrombosis, kidney disease and cancer. The company was founded by August Kongsted and Anton Antons in 1908 and is headquartered in Ballerup, Denmark. | Pharmaceuticals: Major | Director/Board Member | |
| University of Stockholm | College/University | Undergraduate Degree Masters Business Admin | |
| CALLIDITAS THERAPEUTICS AB | Pharmaceuticals: Major | Chief Operating Officer | |
| Royal Institute of Technology | College/University | Undergraduate Degree | |
| University of Lund | College/University | Undergraduate Degree Graduate Degree | |
| University of Gothenburg | College/University | Doctorate Degree Doctorate Degree | |
OxThera AB
 OxThera AB Pharmaceuticals: GenericHealth Technology OxThera AB develops pharmaceutical products for treatment of hyperoxaluria. Its intellectual property includes worldwide patents for compositions and treatment of hyperoxaluria with bacteria and enzymes. The firm?s products in pipeline include Oxabact, for the treatment of primary hyperoxaluria and oxazyme for the prevention of oxalate malabsorption and recurring kidney stones in secondary hyperoxaluria. The company was founded in 2005 and is headquartered in Stockholm, Sweden. | Pharmaceuticals: Generic | Director/Board Member Corporate Officer/Principal | |
| BIOARCTIC AB | Pharmaceuticals: Major | Chief Executive Officer | |
| PHARNEXT SCA | Biotechnology | Chairman | |
AM-Pharma BV
 AM-Pharma BV BiotechnologyHealth Technology AM-Pharma BV operates as a biopharmaceutical company. It engages in the development of proprietary recombinant human Alkaline Phosphatase. The firm’s products include Acute Kidney Injury, Inflammatory Bowel Diseases and Hypophosphatasia. The company was founded in 2001 and is headquartered in Bunnik, the Netherlands. | Biotechnology | Director of Finance/CFO General Counsel | |
Leo Pharma, Inc.
 Leo Pharma, Inc. Drugstore ChainsRetail Trade Leo Pharma, Inc. is engaged in the development, manufacture, and marketing of pharmaceutical drugs. Its products are used for dermatologic and thrombotic patients. The company was founded in 1908 and is headquartered in Parsippany, NJ. | Drugstore Chains | Director/Board Member | |
| The European Medicines Agency | National Agency | Director/Board Member | |
Ventac Partners GmbH
 Ventac Partners GmbH Miscellaneous Commercial ServicesCommercial Services Ventac Partners GMBH offers life sciences consultancy services. Its consulting services include due diligence, education and training, market analysis, product development and valuation. The company was founded by Mikael Oerum in 2002 and is headquartered in Munich, Germany. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Index Invest International AB
 Index Invest International AB Financial ConglomeratesFinance Index Invest International AB provides real estate and equity investment services. Its investment portfolio includes companies in real estate and energy sectors. The company was founded by Bjarne Borg and Fredrik Alama in 1998 and is headquartered in Stockholm, Sweden. | Financial Conglomerates | Director/Board Member | |
NDA Group AB
 NDA Group AB Miscellaneous Commercial ServicesCommercial Services NDA Group AB provides drug developmental consultancy services to the pharmaceutical industry. It focuses on all phases of development and therapeutic areas such as pre-submission, submission, assessment, post authorization, regulatory, pharmacovigilance, and health technology assessment. The company was founded in 1997 and is headquartered in Upplands Väsby, Sweden. | Miscellaneous Commercial Services | Director/Board Member | |
| SWEDISH ORPHAN BIOVITRUM AB | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member | |
| SPAGO NANOMEDICAL AB | Biotechnology | Director/Board Member | |
| Läkemedelsverket | Corporate Officer/Principal | ||
Immedica Pharma AB
 Immedica Pharma AB Medical DistributorsDistribution Services Immedica Pharma AB provides know-how and access of specialty care medicine and products. It also provides information on regulatory and medical affairs and product distribution. The company is headquartered in Stockholm, Sweden. | Medical Distributors | Chairman Founder | |
Global Kinetics Pty Ltd.
 Global Kinetics Pty Ltd. Medical SpecialtiesHealth Technology Global Kinetics Pty Ltd. provides point of care measurement and reporting of Parkinson's disease motor symptoms. Its product includes Personal KinetiGraph (PKG), a wrist worn medical device which reminds the patient when they have taken Levodopa medication as prescribed by doctor. The company was founded by Robert Griffiths and Malcolm Horne in 2007 and is headquartered in Melbourne, Australia. | Medical Specialties | Director/Board Member | |
| INFANT BACTERIAL THERAPEUTICS AB | Pharmaceuticals: Major | Director of Finance/CFO | |
Amolyt Pharma SAS
 Amolyt Pharma SAS Pharmaceuticals: MajorHealth Technology Amolyt Pharma SAS engages in development of biopharmaceutical drugs, proteins and peptides for the treatment of metabolic diseases. The company was founded by Thierry Abribat in 2014 and is headquartered in Ecully, France. | Pharmaceuticals: Major | Director/Board Member | |
| CORLINE BIOMEDICAL AB | Medical Specialties | Director/Board Member | |
| SP Process Development AB | Director/Board Member | ||
| Pharma Executive Consulting Ltd. | Founder | ||
| CODEMILL AB | Packaged Software | Director/Board Member | |
Spinemedical Sverige AB
 Spinemedical Sverige AB Miscellaneous Commercial ServicesCommercial Services Spinemedical Sverige AB provides research and development services on surgical treatment. The private company is based in Stockholm, Sweden. | Miscellaneous Commercial Services | Director/Board Member | |
Spinemedical AB
 Spinemedical AB Medical/Nursing ServicesHealth Services Spinemedical AB provides surgical treatment and rehabilitation services. The private company is based in Stockholm, Sweden. | Medical/Nursing Services | Director/Board Member | |
Lpb Sweden AB
 Lpb Sweden AB Real Estate DevelopmentFinance Lpb Sweden AB provides movable and immovable property services. The private company is based in Stockholm, Sweden. | Real Estate Development | Corporate Officer/Principal | |
Lpb Sweden Holding AB
 Lpb Sweden Holding AB Real Estate DevelopmentFinance Lpb Sweden Holding AB is a Swedish company that owns and manages movable and immovable properties. The private company is based in Stockholm, Sweden. | Real Estate Development | Director/Board Member | |
Epics Therapeutics SA
 Epics Therapeutics SA Miscellaneous Commercial ServicesCommercial Services EPICS Therapeutics SA engages in the development of therapeutic solutions for cancer. The company was founded by Jean Combalbert, Alain Parthoens and Francois Fuks on February 20, 2018 and is headquartered in Charleroi, Belgium. | Miscellaneous Commercial Services | Director/Board Member | |
The Medical Products Agency
 The Medical Products Agency Pharmaceuticals: MajorHealth Technology The Medical Products Agency is a government agency based in Uppsala, Sweden. The agency is responsible for promoting public and animal health in Sweden with regards to pharmaceuticals, medical technology, and cosmetics. The agency is also known as the Swedish Medicines Agency and is tasked with ensuring the safety and efficacy of these products. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| COMPASS PATHWAYS PLC | Biotechnology | Director/Board Member | |
Rare Thyroid Therapeutics International AB
 Rare Thyroid Therapeutics International AB BiotechnologyHealth Technology Rare Thyroid Therapeutics International AB provides thyroid therapeutics research services. The company is headquartered in Stockholm, Sweden. | Biotechnology | Founder Chief Executive Officer | |
Kuste Biopharma SAS
 Kuste Biopharma SAS Pharmaceuticals: MajorHealth Technology Kuste Biopharma SAS engages in the development of therapies for unmet medical inflammatory. The company was founded in 2019 and is headquartered in Lyon, France. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer |
Statistieken
Internationaal
| Zweden | 33 |
| Verenigd Koninkrijk | 5 |
| Verenigde Staten | 4 |
| Australië | 4 |
| Frankrijk | 4 |
Sectoraal
| Health Technology | 26 |
| Consumer Services | 9 |
| Commercial Services | 6 |
| Finance | 4 |
| Technology Services | 3 |
Operationeel
| Director/Board Member | 53 |
| Corporate Officer/Principal | 27 |
| Independent Dir/Board Member | 15 |
| Director of Finance/CFO | 13 |
| Public Communications Contact | 11 |
Sterkste connecties
- Beurs
- Insiders
- Christian Sonesson
- Bedrijfsconnecties